FOXM1 and ovarian carcinoma: To test this possibility, we determined in this study how domatinostat impacts the FOXM1 pathway and cellular properties associated with the pathway, such as proliferation, survival, and sensitivity to chemotherapeutic agents, in ovarian cancer cells.